Tokyo, Apr 8, 2006 (JCN) - Kissei Pharmaceutical announced on April 6 that it has concluded a licensing agreement with GlaxoSmithKline (GSK) for KGA, Kissei Pharmaceutical’s proprietary candidate compound for diabetes drug.
Tokyo, Apr 8, 2006 (JCN) - Kissei Pharmaceutical announced on April 6 that it has concluded a licensing agreement with GlaxoSmithKline (GSK) for KGA, Kissei Pharmaceutical’s proprietary candidate compound for diabetes drug.
